Want to join the conversation?
$BSX,which competes with rivals $MDT, $ABT and $JNJ, said that pacemaker sales grew 3% globally aided by the recently launched X4 CRT-P core device, while worldwide ICD sales fell 4%. The EMBLEM S-ICD is showing strong growth in Europe and US and is currently launching in Japan. Electrophysiology had double-digit growth in Europe.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.